Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1954
HER2amp
Basal A
Nutlin 3a
MDM2
MDM2
7455.066
uM
14.89970
26.82020
-0.7211 -1.0000 1.8690 0.2408
0.9297
1.2976
HCC1954
HER2amp
Basal A
Nutlin 3a
MDM2
MDM2
10469.066
uM
19.19580
33.9010
-0.5820 -1.0000 1.9316 0.1846
0.9742
1.6299
HCC1954
HER2amp
Basal A
Nutlin 3a
MDM2
MDM2
7456.066
uM
17.57180
21.68360
-0.7251 -0.7385 4.3141 0.1284
0.9951
1.7785
HCC1954
HER2amp
Basal A
Olomoucine II
CDK1
CDK
11055.147
uM
9.42270
10.1790
-0.1445 -0.1452 3.3033 0.2378
0.9913
1.6841
HCC1954
HER2amp
Basal A
Omipalisib
PI3K
PI3K
7454.087
uM
0.00381
0.01412
-0.8082 -0.8406 0.7530 1.1374
0.9564
1.2157
HCC1954
HER2amp
Basal A
Omipalisib
PI3K
PI3K
7455.087
uM
0.00452
0.01498
-0.7511 -0.7799 0.7849 1.0832
0.9714
1.2897
HCC1954
HER2amp
Basal A
Omipalisib
PI3K
PI3K
10469.087
uM
0.01496
0.02666
-0.8807 -0.7188 1.5421 0.9721
0.9834
1.5889
HCC1954
HER2amp
Basal A
Omipalisib
PI3K
PI3K
7456.086
uM
0.01717
0.02806
-0.6850 -0.5418 1.4942 0.8480
0.9887
1.8940
HCC1954
HER2amp
Basal A
Oxaliplatin
DNA cross-linker
DNA cross-linker
9386.011
uM
3.4180
28.5410
-0.7075 -1.0000 0.5177 0.5476
0.9779
1.5229
HCC1954
HER2amp
Basal A
Oxamflatin
HDAC
HDAC
11055.147
uM
1.93950
6.84940
-0.8576 -1.0000 0.8707 0.4123
0.9906
1.6841
HCC1954
HER2amp
Basal A
PD 98059
MEK
MAPK
11055.152
uM
inf
14.73220
0.7941 0.7936 4.8318 0.0077
0.8678
1.6647
HCC1954
HER2amp
Basal A
PD173074
FGFR1/3
RTK
7454.093
uM
6.96930
10.61220
-0.9082 -1.0000 2.6127 0.2961
0.9308
1.3347
HCC1954
HER2amp
Basal A
PD173074
FGFR1/3
RTK
10469.1
uM
13.60020
21.24230
-0.8972 -1.0000 2.4637 0.2076
0.9920
1.5717
HCC1954
HER2amp
Basal A
PD173074
FGFR1/3
RTK
7455.093
uM
8.3870
16.49190
-0.5182 -1.0000 1.6247 0.1314
0.9962
1.7255
HCC1954
HER2amp
Basal A
PD184352
MEK
MAPK
11055.155
uM
23.75260
483.87240
0.4233 -1.0000 0.3645 0.1483
0.9484
1.7439
HCC1954
HER2amp
Basal A
PD184352
MEK
MAPK
11055.155
uM
23.75260
483.87240
0.4233 -1.0000 0.3645 0.1483
0.9484
1.7439
HCC1954
HER2amp
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7457.094
uM
inf
inf
0.8077 0.8077 0.0000 0.2414
0.0000
1.8462
HCC1954
HER2amp
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7455.095
uM
inf
inf
-0.6708 -0.6708 0.0000 0.3794
0.1820
1.8461
HCC1954
HER2amp
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7454.095
uM
inf
inf
0.7171 0.7171 0.0000 0.1308
0.4162
1.1351
HCC1954
HER2amp
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7456.095
uM
0.31496
0.15636
0.3219 0.3530 1.7478 0.5024
0.9703
1.9589
HCC1954
HER2amp
Basal A
PS-1145
IKK
NFKB
7454.065
uM
inf
inf
0.7779 0.7779 0.0000 0.1159
0.0469
1.0489
HCC1954
HER2amp
Basal A
PS-1145
IKK
NFKB
7457.065
uM
inf
inf
0.8494 0.8494 0.0000 0.0471
0.0632
1.5870
HCC1954
HER2amp
Basal A
PS-1145
IKK
NFKB
7456.065
uM
inf
999.90580
0.6448 0.3898 0.3762 0.1040
0.7152
1.9899
HCC1954
HER2amp
Basal A
PS-1145
IKK
NFKB
7455.065
uM
inf
217.63220
0.6989 0.6976 2.5631 0.0690
0.9103
1.7441
HCC1954
HER2amp
Basal A
Purvalanol A
CDK1
CDK
7456.067
uM
inf
inf
0.6461 0.6461 0.0000 0.0807
0.4257
1.8797